Broadfin Capital, LLC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 88 filers reported holding ANTARES PHARMA INC in Q3 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
Broadfin Capital, LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q3 2019$4,471,000
-22.1%
1,336,700
-23.4%
0.83%
-33.7%
Q2 2019$5,738,000
-28.4%
1,744,147
-34.0%
1.25%
-24.5%
Q1 2019$8,011,000
-14.5%
2,643,947
-23.2%
1.65%
+34.3%
Q4 2018$9,368,000
-39.7%
3,444,147
-25.5%
1.23%
-46.1%
Q3 2018$15,534,000
+30.2%
4,623,2470.0%2.29%
+21.7%
Q2 2018$11,928,000
+16.0%
4,623,247
-1.1%
1.88%
+17.2%
Q1 2018$10,281,000
+13.9%
4,673,247
+3.0%
1.60%
+8.6%
Q4 2017$9,026,000
-13.1%
4,535,647
+41.5%
1.48%
-4.0%
Q3 2017$10,387,000
-32.8%
3,205,900
-33.3%
1.54%
-18.2%
Q2 2017$15,467,000
-28.7%
4,803,528
-37.1%
1.88%
-28.5%
Q1 2017$21,704,000
-28.2%
7,642,206
-41.1%
2.63%
-21.6%
Q4 2016$30,223,000
+20.9%
12,971,093
-12.9%
3.36%
+49.7%
Q3 2016$25,007,000
+60.0%
14,885,3930.0%2.24%
+47.4%
Q2 2016$15,630,000
+19.1%
14,885,393
-1.3%
1.52%
+19.9%
Q1 2016$13,126,000
-5.5%
15,085,393
+31.5%
1.27%
+48.5%
Q4 2015$13,885,000
-3.6%
11,475,000
+35.4%
0.85%
+6.5%
Q3 2015$14,408,000
-8.6%
8,475,000
+11.9%
0.80%
-5.3%
Q2 2015$15,756,000
+23.7%
7,575,000
+61.2%
0.85%
-14.6%
Q1 2015$12,737,000
-47.3%
4,700,000
-50.0%
0.99%
-5.5%
Q4 2014$24,158,000
+256.8%
9,400,000
+154.1%
1.05%
+47.9%
Q3 2014$6,771,000
-58.4%
3,700,000
-39.3%
0.71%
-11.5%
Q2 2014$16,288,000
+102.3%
6,100,000
+165.2%
0.80%
+2.8%
Q1 2014$8,050,000
+125.0%
2,300,000
+187.5%
0.78%
+65.3%
Q4 2013$3,577,000800,0000.47%
Other shareholders
ANTARES PHARMA INC shareholders Q3 2015
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders